21478 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
BIO-ACTIVATED REPORTERS TO VISUALIZE, IN REAL TIME, SPECIFIC GENE THERAPY PRODUCTS
#2POLYMER CONTRAST AGENT
#3NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT
#4GADOLINIUM-BASED COMPOUND, AND MRI CONTRAST AGENT INCLUDING SAME
#5FORMULATION OF CONTRAST MEDIA AND PROCESS OF PREPARATION THEREOF
#6COMPOSITION AND METHODS FOR IMAGING CELLS
#7MRI-AGENT LOADED PLATELET COMPOSITIONS AND METHODS OF PREPARING AND USING THE SAME
#8Pharmaceutical composition with nanoparticle-based drug delivery combined with non-invasive radiographic monitoring model
#9COMPOSITIONS AND METHODS FOR TARGETING CELLS
#10BIOCOMPATIBLE IMAGING PARTICLES, THEIR SYNTHESIS AND USE IN IMAGING TECHNIQUES
#11FLUORESCENCE-MAGNETIC RESONANCE DUAL-MODALITY CONTRAST AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF
#12Human Anti-SOD1 Antibodies
#13Formulation of contrast media and process of preparation thereof
#14NEW CONTRAST AGENT FOR USE IN MAGNETIC RESONANCE IMAGING
#15CYCLIC DINUCLEOTIDE CONJUGATES AND RELATED METHODS OF USE THEREOF
#16RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE
#17DETECTION OF HIGH-RISK UNSTABLE ATHEROSCLEROTIC PLAQUE
#18FIBROBLAST ACTIVATION PROTEIN-TARGETED MAGNETIC RESONANCE IMAGING AGENTS, COMPOSITIONS, AND METHODS OF USE
#19TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION
#20NANOBODY BASED IMAGING AND TARGETING OF ECM IN DISEASE AND DEVELOPMENT
#21METHOD OF SYNTHESIZING 18F RADIOLABELED BIOMOLECULAR AGENTS
#22Long-Lived Gadolinium Based Tumor Targeted Imaging and Therapy Agents
#23Compositions and Methods for Treating Neurological-associated Disorders
#24NANOCOMPOSITES OF NITROGEN-DOPED GRAPHENE OXIDE AND MANGANESE OXIDE FOR PHOTODYNAMIC THERAPY AND MAGNETIC RESONANCE IMAGING
#25TEXAPHYRIN-PT(IV) CONJUGATES AND COMPOSITIONS FOR USE IN OVERCOMING PLATINUM RESISTANCE
#26NOVEL GADOLINIUM-BASED COMPOUND, PREPARATION METHOD THEREFOR, AND MRI CONTRAST AGENT CONTAINING SAME
#27SEQUENTIAL TARGETING IN CROSSLINKING NANO-THERANOSTICS FOR TREATING BRAIN TUMORS
#28FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY OF CANCERS AND OTHER FIBROTIC AND INFLAMMATORY DISEASES
#29Recombinant chimeric protein for selectins targeting
#30Human Anti-SOD1 Antibodies
#31Targeted contrast agents for MRI of alpha-synuclein deposition
#32COMPOUNDS FOR USE AS IRON(III) MRI CONTRAST AGENTS
#33Coated plant virus imaging agents
#34HEPARANASE COMPOUNDS AND METHODS OF USE
#35STICKY PARTICLES FOR EFFICIENT IMAGING
#36MRI CONTRAST AGENT FOR USE IN THE DIAGNOSIS OF EARLY CHANGES IN THE ENDOTHELIUM OF BLOOD VESSELS
#37Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer
#38Biocompatible magnetic materials
#39Graphene quantum dots-gadolinium ion chelate as magnetic resonance imaging contrast agent and preparation method thereof
#40Formulation of contrast media and process of preparation thereof
#41PEPTIDES AND COMPOSITIONS FOR TARGETED TREATMENT AND IMAGING
#42DETECTION OF HIGH-RISK UNSTABLE ATHEROSCLEROTIC PLAQUE
#43TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION
#44Cyclodextrin-linked polyvalent ligands for complexation of metal ions
#45Heterochiral peptide-complex and composition for measuring nuclear magnetic resonance spectroscopy residual dipolar coupling containing self-assembled intermediates of heterochiral peptide-complex
#46HALOGENATED BIOTIN-MODIFIED DIMER AND USE THEREOF
#47TARGETING LIGANDS FOR TAU PATHOLOGY
#48METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER
#49PH and Oxygen dual-sensitive magnetic resonance imaging contrast agent and preparation method thereof
#50Compositions and methods for targeting cells
#51BIO-ACTIVATED REPORTERS TO VISUALIZE, IN REAL TIME, SPECIFIC GENE THERAPY PRODUCTS
#52Manganese-based chelate conjugates for molecular MR imaging
#53Long-lived gadolinium based tumor targeted imaging and therapy agents
#54Coated plant virus imaging agents
#55SALICYLIC ACID-BASED POLYMERIC CEST CONTRAST AGENTS TARGETING PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND USES THEREOF
#56MALIGNANT TUMOR TARGET PEPTIDE
#57TETRAPYRROLIC CONJUGATES AND USES THEREOF FOR IMAGING
#58BIOTIN COMPLEXES FOR TREATMENT AND DIAGNOSIS OF ALZHEIMER'S DISEASE
#59Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer
#60Development of injectable fiducial markers for image guided radiotherapy with dual MRI and CT visibility
#61LONG-CIRCULATING THERANOSTIC AGENTS FOR DIAGNOSING AND IMAGING METASTATIC TUMORS
#62COMPOSITIONS AND METHODS FOR DETECTING HUMAN PEGIVIRUS 2 (HPgV-2)
#63TARGETED CONTRAST AGENTS AND METHODS FOR TARGETING CONTRAST AGENTS
#64Compounds for use as iron(III) MRI contrast agents
#65Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance
#66Composition and methods for imaging cells
#67ENCAPSULATED DIAGNOSTICS AND THERAPEUTICS IN NANOPARTICLES - CONJUGATED TO TROPIC CELLS AND METHODS FOR THEIR USE
#68POLYMALIC ACID BASED NANOCONJUGATES FOR IMAGING
#69Gd(III)-dithiolane gold nanoparticle conjugates
#70Human anti-SOD1 antibodies
#71Imaging compositions
#72BIOCOMPATIBLE MAGNETIC MATERIALS
#73Metal complexes with bisphophonate or pyrophosphate useful as imaging agents
#74TEXAPHYRIN AND ANTITUMOR ANTIBIOTIC CONJUGATES
#75Nanobody based imaging and targeting of ECM in disease and development
#76Tetrapyrroles conjugates as MRI contrast agent
#77CHEMICAL PROBES OF LYSYL OXIDASK-LIKE 2 AND USES THEREOF
#78Cell-permeable imaging sensors and uses thereof
#79Long-lived gadolinium based tumor targeting imaging and therapy agents
#80Malignant tumor target peptide
#81Manganese complexes with substituted bisphosphonates useful as imaging and therapeutic agents
#82Composition intended to vectorise an anti-cancer agent
#83Antibodies and related molecules and uses thereof
#84Recombinant chimeric protein for selectins targeting
#85Blood-brain barrier permeable peptide compositions comprising a VAB domain of an anti-amyloid-beta camelid single-domain heavy-chain only antibody
#86Manganese-based chelate conjugates for molecular MR imaging
#87Molecular probes for imaging of myelin
#88Salicylic acid-based polymeric CEST contrast agents targeting prostate-specific membrane antigen and uses thereof
#89Coated plant virus imaging agents
#90Compositions and methods for detecting human pegivirus 2 (HPgV-2)
#91Environmentally sensitive compositions comprising a pH-triggered membrane protein and methods of use thereof in the treatment and diagnosis of tumors
#92CONTRAST AGENT FOR IMAGING HYPOXIA
#93COLLAGEN IMAGING COMPOSTIONS
#94Nanoparticles
#95Cathepsin-binding compounds bound to a carrier and their diagnostic use
#96Homing agents
#97AGENTS FOR USE IN THE DETECTION OF NUCLEASE ACTIVITY
#98Targeted contrast agents comprising a hydrazide functional group
#99Biotin complexes for treatment and diagnosis of Alzheimer'S disease
#100Compositions and methods for detecting human pegivirus 2 (HPgV-2)
#101Texaphyrin-Pt(IV) conjugates and compositions for use in overcoming platinum resistance
#102Method and compositions for orally administered contrast agents for MR imaging
#103Metal complexes with bisphosphonate useful as imaging agents
#104Glucose conjugated gold nanoparticle
#105Gadolinium expressed lipid nanoparticles for magnetic resonance imaging
#106Nanosensor Compositions and Methods of use Thereof
#107Long-lived gadolinium based tumor targeted imaging and therapy agents
#108Liposomes useful for drug delivery to the brain
#109Peptides whose uptake by cells is controllable
#110Collagen imaging compositions
#111Gd(III)-dithiolane gold nanoparticle conjugates
#112Methods and compounds for enhancing contrast in magnetic resonance imaging (MRI)
#113Oligopeptide and methods for producing conjugates thereof
#114Tumour-targeted theranostic
#115Environmentally sensitive compositions and methods of use thereof
#116Targeted contrast agents and methods for targeting contrast agents
#117Imaging beta-amyloid peptides aggregation
#118MRI CONTRAST AGENTS FOR CELL LABELING
#119Biodegradable organic radical-functionalized polycarbonates for medical applications
#120Human anti-SOD1 antibodies
#121Recombinant self-assembling protein comprising target-oriented peptide and use thereof
#122Coated plant virus imaging agents
#123Metallocene compounds and labeled molecules comprising the same for in vivo imaging
#124Targeting aptamer for atherosclerosis and preparation method and application thereof
#125MR IMAGING DIAGNOSTIC AGENT FOR INTRACTABLE NEUROLOGICAL DISEASE
#126Magnetic nanoparticle composition and manufacturing method and use thereof
#127NANOPARTICLES FOR BRAIN TUMOR IMAGING
#128Dual mode gadolinium nanoparticle contrast agents
#129Paramagnetic solid lipid nanoparticles (pSLNs) containing metal amphiphilic complexes for MRI
#130Biotin complexes for treatment and diagnosis of alzheimer's disease
#131Contrast Agent and Applications Thereof
#132COMPOUNDS HAVING MAGNETIC FUNCTIONALITY, IMPLANTS OR GELS DERIVED FROM SAME, AND USE OF BOTH IN ORDER TO DETERMINE THE ENZYME ACTIVITY OF AN ENZYME
#133Compositions and methods to evaluate hepatobiliary/gastrointestinal health, enterohepatic circulation, and drug interactions
#134Fluorescent neutralization and adherence inhibition assays
#135Lysine oligomer derivative and cartilage tissue marker made thereof
#136N-alkoxyamide conjugates as imaging agents
#137Nanoparticles/theranostic vehicles
#138Encapsulated diagnostics and therapeutics in nanoparticles—conjugated to tropic cells and methods for their use
#139Caspase-triggered nano-aggregation probes and methods of use
#140Environmentally sensitive compositions and methods of use in the treatment and diagnosis of tumors
#141Dynamic contrast enhanced MRI method and agents for the assessment of the macromolecular transport within pathologic tissues
#142Methods to regulate polarization and enhance function of cells
#143Homing agents
#144Methods and compositions related to targeting tumors and wounds
#145Hydrophobic modified peptides for liver specific diagnosis
#146Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
#147Human anti-SOD1 antibodies
#148Bacteria-targeted magnetic resonance contrast agents
#149Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide
#150MRI CONTRAST ENHANCING AGENT
#151Targeted theranostics
#152Cathepsin-binding compounds bound to a carrier and their diagnostic use
#153Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation
#154Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation
#155Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
#156Cyclic lactadherin peptide mimetics and their uses
#157Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
#158Method for the detection of enzymatic activity with magnetically functionalized substrates
#159Lipidomimetic compounds and uses thereof
#160TARGETED CONTRAST AGENTS AND USES THEREOF
#161Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#162Methods to regulate polarization and enhance function of cells
#163MULTIFUNCTIONAL NANOPARTICLES
#164NOVEL TARGETED PARAMAGNETIC CONTRAST AGENT
#165Functionalized Magnetic Nanoparticles and Methods of Use Thereof
#166MMP-targeted therapeutic and/or diagnostic nanocarriers
#167Compositions useful for target, detection, imaging and treatment, and methods of production and use thereof
#168Quantum dot materials, methods for making them, and uses thereof
#169Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
#170Compositions and methods to prevent cancer with cupredoxins
#171Activatable cell penetrating peptides with quenched fluorophores
#172Compositions and methods comprising magnetic resonance contrast agents
#173IMAGING AGENTS OF FIBROTIC DISEASES
#174Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof
#175Magnetic nanoparticle with biocompatibility
#176N-alkoxyamide conjugates as imaging agents
#177Fibrin-binding peptides and conjugates thereof
#178Imaging beta-amyloid peptides and inhibition of beta-amyloid peptide aggregation
#179Protein agent for diabetes treatment and β cell imaging
#180Compositions that include a hydrophobic compound and a polyamino acid conjugate
#181Composition and methods for imaging cells
#182METHOD FOR THE PRODUCTION OF SCAFFOLDS FOR TISSUE ENGINEERING, COMPRISING THE USEOF AN ANCHORING UNIT, AND SCAFFOLD PRODUCED THEREWITH
#183MULTI-FUNCTIONAL DRUG CARRIERS
#184ε-Polylysine conjugates and the use thereof
#185VITAL FLUOROCHROME CONJUGATES AND METHODS OF USE
#186Diagnostic imaging contrast agents with extended blood retention
#187IMAGING GASTROINTESTINAL VOLUMES AND MOTILITY
#188Fucoidans as Ligands for the Diagnosis of Degenerative Pathologies
#189GADOLINIUM EXPRESSED LIPID NANOPARTICLES FOR MAGNETIC RESONANCE IMAGING
#190FLUORESCENT MRI PROBE
#191Peptides whose uptake by cells is controllable
#192Gastrin releasing peptide compounds
#193TARGETING NPR-C IN ANGIOGENESIS AND ATHEROSCLEROSIS WITH A C-TYPE ATRIAL NATRIURETIC FACTOR (CANF)-COMB NANOCOMPLEX
#194Methods of treating autoimmune disorders and/or inflammatory disorders
#195Intravascular contrast agents
#196Living copolymer-protein/peptide hybrids for biomedical applications
#197Contrast agents endowed with high relaxivity
#198SINGLE-STRANDED AND DOUBLE-STRANDED OLIGONUCLEOTIDES COMPRISING A METAL-CHELATING LIGAND
#199Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GBexpressing tumors
#200SMART CONTRAST AGENTS FOR MRI IMAGING
#201PEPTIDE TARGETING IMAGING AGENTS AND METHODS OF USE THEREOF
#202CONJUGATES OF 19F MR IMAGING TRACERS FOR USE IN MULTI-CHROMIC MRI IMAGING
#203Compositions and methods for enhancing drug delivery across and into epithelial tissues
#204VECTOR FOR USE IN MEDICINE
#205Molecular probes for imaging of myelin
#206METHOD FOR THE DETECTION OF ENZYMATIC ACTIVITY WITH MAGNETICALLY FUNCTIONALIZED SUBSTRATES
#207BIOCOMPATIBLE POLYMER AND MAGNETIC NANOPARTICLE WITH BIOCOMPATIBILITY
#208Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
#209Polymerized cyclic nitroxide radical compound and use thereof
#210Conjugates for medical imaging comprising carrier, targeting moiety and a contrast agent
#211CONJUGATES OF 19F MR IMAGING TRACERS AND CHEMOTHERAPEUTIC AGENTS FOR DRUG QUANTIFICATION AND DRUG DOSE INDIVIDUALIZATION
#212TREATMENT MONITORING
#213Diagnostic agents selective against metalloproteases
#214Functionalized magnetic nanoparticles and methods of use thereof
#215Elastin-like polypeptide and gadolinium conjugate for magnetic resonance imaging
#216Xe biosensors and their use
#217Flexibly labeling peptides
#218Compounds comprising a biological target recognizing part, coupled to a signal part capable of complexing gallium
#219Methods Of Coupling Multidentate AZA Ligands To Targeting Molecules
#220Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#221DETECTING IONS AND MEASURING ION CONCENTRATIONS
#222RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and Imaging of Necrotic tumors
#223IN VIVO IMAGING
#224Agents for detecting and imaging cell death
#225FLUORINATED LANTHANIDE PROBES FOR 19F MAGNETIC RESONANCE APPLICATIONS
#226ULTRA-SMALL CHITOSAN NANOPARTICLES USEFUL AS BIOIMAGING AGENTS AND METHODS OF MAKING SAME
#227Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to GB3 expressing tumors
#228Imaging method
#229Agents for magnetic imaging method
#230COMPLEX OF CELL TRANSLOCATIONAL PEPTIDE AND MAGNETIC NANOPARTICLES AND USE THEREOF
#231Particles for imaging
#232Diagnostic agent
#233USE OF MRI CONTRAST AGENTS FOR EVALUATING THE TREATMENT OF TUMORS
#234Magnetic resonance imaging contrast agents
#235Nanoparticles for brain tumor imaging
#236Compositions comprising nucleic acid aptamers
#237Use of non-canonical amino acids as metabolic markers for rapidly-dividing cells
#238SMART CONTRAST AGENT AND METHOD FOR DETECTING TRANSITION METAL IONS AND TREATING RELATED DISORDERS
#239Nuclear translocation peptide
#240Fibrin binding peptide conjugates for diagnostic and therapeutic applications
#241Annulus fibrosus detection in intervertebral discs using molecular imaging agents
#242PARAMAGNETIC BIOMOLECULE COMPLEXES AND USES THEREOF IN THE ASSESSMENT OF ORGAN FUNCTION
#243MULTIMODAL IMAGING PROBES FOR IN VIVO TARGETED AND NON-TARGETED IMAGING AND THERAPEUTICS
#244GUANIDINIUM DELIVERY CARRIERS
#245Fibrin-binding peptides and conjugates thereof
#246COMPOUNDS FOR THE DIAGNOSIS OF APOPTOSIS
#247SMART CONTRAST AGENT AND DETECTION METHOD FOR DETECTING TRANSITION METAL IONS
#248Fluorescent neutralization and adherence inhibition assays
#249Multidentate AZA ligands able to complex metal ions and the use thereof in diagnostics and therapy
#250Method of preparing macromolecular contrast agents and uses thereof
#251Two helix binders
#252COMPOSITIONS AND METHODS COMPRISING MAGNETIC RESONANCE CONTRAST AGENTS
#253Natriuretic peptide-mediated imaging of atherosclerotic plaque
#254Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases
#255RADIOFLUORINATION METHODS
#256Contrast agents
#257Highly fluorinated oils and surfactants and methods of making and using same
#258COX-2-TARGETED IMAGING AGENTS
#259Higher fatty acid triester and amide derivative having diethylenetriamine-type metal chelate structure
#260Imaging agents and methods of using same for detecting multidrug resistance in cancer
#261Lipophilic chelates and their use in imaging
#262Methods and compositions related to targeting tumors and wounds
#263Targeted Nanostructures for Cellular Imaging
#264Contrast agents
#265Diagnostic compounds for targeting a chemokine receptors
#266Process for preparing particles of proteinaceous material
#267PDGF-Rβ binders
#268Gastrin releasing peptide compounds
#269Compounds comprising short aminoalcohol chains and metal complexes for medical imaging
#270METHOD FOR THE SYNTHESIS OF PENTA-PENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIOCONJUGATES PREPARATION BY A COVALENT BINDING THEREOF
#271Glyco-molecular imaging method for grade classification of liver fibrosis and its glyco-molecular imaging agent thereof
#272Activatable cest MRI agent
#273GLYCEROL ESTER DERIVATIVE HAVING METAL CHELATE STRUCTURE
#274SUPRAMOLECULAR AGGREGATES CONTAINING CHELATING AGENTS AND BIOACTIVE PEPTIDES AS EFFECTIVE AND SELECTIVE DELIVERY TOOLS FOR DRUGS AND CONTRAST AGENTS IN MRI OR NUCLEAR MEDICINE
#275Cannabinoid receptor targeted agent
#276Targeted contrast agents and methods for targeting contrast agents
#277Octameric Protein For Use In Bionanotechnology Applications
#278Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates
#279MRI-Guided Photodynamic Therapy For Cancer
#280Compositions and methods for magnetic resonance imaging contrast agents
#281RADIOFLUORINATION
#282MRI contrast agents endowed with concentration independent responsiveness
#283Polybiotin compounds of magnetic resonance imaging and drug delivery
#284Methods and compositions for delivering active agents with enhanced pharmacological properties
#285Mri Contrast Agents for Diagnosis and Prognosis of Tumors
#286Higher fatty acid triester compound having diethylenetriamine-type metal chelate structure
#287POLYMERS CONJUGATED WITH PLATINUM DRUGS
#288Glycosylated Carboranylporphyrins and Uses Thereof
#289POLYGLUTAMATE CONJUGATES AND POLYGLUTAMATE-AMINO ACID CONJUGATES HAVING A PLURALITY OF DRUGS
#290Compositions that include a hydrophobic compound and a polyamino acid conjugate
#291Enzyme Inhibitor Imaging Agents
#292Staudinger Reaction in Imaging and Therapy and Kits for Use in Imaging and Therapy
#293Targeted Imaging And/Or Therapy Using The [3+2] Azide-Alkyne Cycloaddition
#294MULTI-FUNCTIONAL POLYGLUTAMATE DRUG CARRIERS
#295Compositions and methods to prevent cancer with cupredoxins
#296NOVEL CASCADE POLYMER COMPLEXES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
#297Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
#298Preparation of Paramagnetic Nanoparticles Conjugated to Leukotriene B4 (LTB4) Receptor Antagonists, and Their Use as MRI Contrast Agents for the Detection of Infection and Inflammation
#299Multi-functional Drug Carriers
#300NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF